Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
David Z.I. Cherney
ResearcherPublications, citations & collaboration network
David Z.I. Cherney is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 561 works, 27,261 citations, an h-index of 79 and an i10-index of 307.
561
Works
27,261
Citations
79
h-index
307
i10-index
How has David Z.I. Cherney's publication output changed over time?
ScholarIQpublication output · 2013–2022
Output grew0% over the shown period — from 1 works in 2013 to 1 in 2022.
1
1
1
2
2
4
1
2013201420162017201820202022
What are the most-cited papers on David Z.I. Cherney?
ScholarIQmost cited works
Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes
Christopher P. Cannon, Richard E. Pratley, Samuel Dagogo‐Jack, James P. Mancuso, Susan Huyck, Urszula Masiukiewicz, B Charbonnel, Robert Frederich, Silvina Gallo, Francesco Cosentino, Weichung Shih, Ira Gantz, Steven G. Terra, David Z.I. Cherney, Darren K. McGuire
New England Journal of Medicine. 20201,509 CitationsOPEN ACCESS
Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus
Hiddo J.L. Heerspink, Bruce A. Perkins, David Fitchett, Mansoor Husain, David Z.I. Cherney
Circulation. 20161,367 Citations
Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus
David Z.I. Cherney, Bruce A. Perkins, Nima Soleymanlou, M Maione, Vesta Lai, Alana Lee, Nora Fagan, Hans J. Woerle, Odd Erik Johansen, Uli C. Broedl, Maximilian von Eynatten
Circulation. 20131,319 CitationsOPEN ACCESS
Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes
Darren K. McGuire, Weichung Shih, Francesco Cosentino, B Charbonnel, David Z.I. Cherney, Samuel Dagogo‐Jack, Richard E. Pratley, Michelle Greenberg, Shuai Wang, Susan Huyck, Ira Gantz, Steven G. Terra, Urszula Masiukiewicz, Christopher P. Cannon
JAMA Cardiology. 20201,231 CitationsOPEN ACCESS
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease
Deepak L. Bhatt, Michael Szarek, Bertram Pitt, Christopher P. Cannon, Lawrence A. Leiter, Darren K. McGuire, Julia B. Lewis, Matthew C. Riddle, Silvio E. Inzucchi, Mikhail Kosiborod, David Z.I. Cherney, Jamie P. Dwyer, Benjamin M. Scirica, Clifford J. Bailey, Rafael Díaz, Kausik K. Ray, Jacob A. Udell, Renato D. Lópes, Pablo Lapuerta, Philippe Gabríel Steg
New England Journal of Medicine. 20201,185 CitationsOPEN ACCESS
Related on ScholarIQ
University Health Network
Institution
Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes
Paper
Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus
Paper
Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus
Paper
Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes
Paper
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease
Paper